PCT (pressure cycling technology) to be developed for clinical diagnostics:
This article was originally published in Clinica
Executive Summary
Boston Biomedica has signed a co-operative R&D agreement with the US National Institutes of Health Clinical Center to develop clinical diagnostic applications of the company's pressure cycling technology (PCT). PCT is a new technology that uses pressure rather than temperature to control chemical reactions. The technology is claimed to lower the risk of infection among laboratory workers and provide more rapid, sensitive and accurate diagnosis. West Bridgewater, Massachusetts-based Boston Biomedica acquired the PCT technology when it purchased Bio Seq in 1998.